» Authors » Fang-Lan Yu

Fang-Lan Yu

Explore the profile of Fang-Lan Yu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 120
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Chen F, Jean S, Ou T, Wang G, Yu F, Lee W
J Microbiol Immunol Infect . 2017 Jul; 50(3):399-400. PMID: 28698041
No abstract available.
3.
Ou T, Chang F, Cheng W, Lara A, Chou M, Lee W, et al.
J Microbiol Immunol Infect . 2016 Mar; 50(6):899-904. PMID: 26928371
Background: Candida albicans, a common fungal pathogen that can cause opportunistic infections, is regarded as an apparently asexual, diploid fungus. A parasexual cycle was previously found between homozygotes with opposite...
4.
Hsieh T, Hsueh P, Yu F, Jean S, Chen F, Ou T, et al.
J Microbiol Immunol Infect . 2015 Dec; 49(2):309-10. PMID: 26712093
No abstract available.
5.
Lee W, Hsueh P, Yu F, Chen F, Hsieh T, Ou T
J Microbiol Immunol Infect . 2015 Jun; 50(3):395-396. PMID: 26074282
No abstract available.
6.
Lee W, Hsieh T, Ou T, Chen F, Yu F, Jean S, et al.
J Microbiol Immunol Infect . 2015 Feb; 50(1):123-124. PMID: 25649488
No abstract available.
7.
Teng S, Yen M, Ou T, Chen F, Yu F, Lee W
J Microbiol Immunol Infect . 2014 Aug; 48(5):525-30. PMID: 25103719
Objective: Acinetobacter baumannii (AB) bacteremia has increasingly emerged as a nosocomial pathogen in healthcare settings, associated with high patient morbidity and mortality. The objective of this study was to compare...
8.
Yu F, Lee J, Wang M, Hsu H, Chen T, Cheng C, et al.
J Microbiol Immunol Infect . 2014 Mar; 49(1):60-5. PMID: 24662015
Background/purpose: The emergence of resistance to anti-tuberculosis (TB) drugs has become an obstacle to effective TB control. Thus, there is an urgent need to identify patients and initiate adequate treatment...
9.
Chen F, Wang G, Teng S, Ou T, Yu F, Lee W
J Microbiol Immunol Infect . 2012 Oct; 46(6):425-32. PMID: 23022462
Purpose: This study investigates the clinical and epidemiological features of Chryseobacterium indologenes infections and antimicrobial susceptibilities of C indologenes. Methods: With 215 C indologenes isolates between January 1, 2004 and...
10.
Shen W, Chiang Y, Chen H, Chen T, Yu F, Tang C, et al.
Nephrology (Carlton) . 2011 Jun; 16(8):697-703. PMID: 21707841
Aim: Vancomycin and teicoplanin are the two most used glycopeptides for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). Vancomycin is suspected to have more nephrotoxicity but this has not been...